Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 6/20 | 0.63 |
| ▸ | RAB9A | P51151 | 6/20 | 0.63 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.63 |
| ▸ | LMNA | P02545 | 4/20 | 0.63 |
| ▸ | NPC1 | O15118 | 4/20 | 0.63 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.63 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.60 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.60 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.60 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.60 |
| ▸ | SRD5A2 | P31213 | 2/20 | 0.54 |
| ▸ | HPGD | P15428 | 1/20 | 0.52 |
| ▸ | SRD5A1 | P18405 | 1/20 | 0.49 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.49 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.49 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.49 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.49 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.49 |
| ▸ | GAA | P10253 | 1/20 | 0.48 |
| ▸ | MEN1 | O00255 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30935799 | 1.00 | MAPT (0.63) | MAPTRAB9AALDH1A1LMNANPC1 | |
| SCHEMBL22801020 | 0.82 | TDP1 (0.57) | MAPTRAB9AALDH1A1LMNANPC1 | |
| SCHEMBL21027974 | 0.81 | TDP1 (0.51) | MAPTRAB9AALDH1A1LMNANPC1 | |
| SCHEMBL22801022 | 0.80 | KMT2A (0.54) | MAPTRAB9AALDH1A1LMNANPC1 | |
| SCHEMBL26809636 | 0.80 | TDP1 (0.54) | MAPTRAB9AALDH1A1LMNANPC1 | |
| SCHEMBL312287 | 0.80 | KMT2A (0.92) | MAPTRAB9AALDH1A1LMNANPC1 | |
| SCHEMBL6994441 | 0.79 | MAPT (0.60) | MAPTRAB9AALDH1A1LMNANPC1 | |
| SCHEMBL11258682 | 0.79 | MAOA (0.60) | MAPTRAB9AALDH1A1LMNANPC1 | |
| SCHEMBL27359064 | 0.79 | TDP1 (0.53) | MAPTRAB9AALDH1A1LMNANPC1 | |
| SCHEMBL6002245 | 0.79 | KMT2A (0.70) | MAPTRAB9AALDH1A1LMNANPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112839979-B | Method for preparing releasable polymeric reagents | 尼克塔治疗公司 | 2024-06-21 | — | — | CN | disclosed |
| US-11932726-B2 | Method of making releasable polymeric reagents | NEKTAR THERAPEUTICS (US) | 2024-03-19 | — | — | US | disclosed |
| US-20220143201-A1 | COMPOSITION COMPRISING A POLYMERIC REAGENT | NEKTAR THERAPEUTICS (US) | 2022-05-12 | — | — | US | disclosed |
| US-11266742-B2 | Conjugates having a degradable linkage and polymeric reagents useful in preparing such conjugates | NEKTAR THERAPEUTICS (US) | 2022-03-08 | — | — | US | disclosed |
| US-20210388161-A1 | METHOD OF MAKING RELEASABLE POLYMERIC REAGENTS | NEKTAR THERAPEUTICS | 2021-12-16 | — | — | US | disclosed |
| EP-3864068-A2 | METHOD OF MAKING RELEASABLE POLYMERIC REAGENTS | Nektar Therapeutics (US) | 2021-08-18 | — | — | EP | disclosed |
| CN-112839979-A | Method for preparing releasable polymeric reagents | 尼克塔治疗公司 | 2021-05-25 | — | — | CN | disclosed |
| US-20200276320-A1 | COMPOSITION COMPRISING A POLYMERIC REAGENT | NEKTAR THERAPEUTICS (US) | 2020-09-03 | — | — | US | disclosed |
| US-10695435-B2 | Composition comprising a polymeric reagent | NEKTAR THERAPEUTICS (US) | 2020-06-30 | — | — | US | disclosed |
| US-20190046651-A1 | COMPOSITION COMPRISING A POLYMERIC REAGENT | NEKTAR THERAPEUTICS | 2019-02-14 | — | — | US | disclosed |
| US-20140107349-A1 | Methods for Preparing Polymeric Reagents | NEKTAR THERAPEUTICS (US) | 2014-04-17 | — | — | US | disclosed |
| US-20130184443-A1 | Methods for Preparing Conjugates | NEKTAR THERAPEUTICS (US) | 2013-07-18 | — | — | US | disclosed |
| US-8435505-B2 | Pharmaceutical compositions and methods for delivering such compositions | NEKTAR THERAPEUTICS (US) | 2013-05-07 | — | — | US | disclosed |
| EP-1896082-B1 | CONJUGATES HAVING A DEGRADABLE LINKAGE AND POLYMERIC REAGENTS USEFUL IN PREPARING SUCH CONJUGATES | NEKTAR THERAPEUTICS (US) | 2012-12-26 | — | — | EP | disclosed |
| US-20120258912-A1 | PHARMACEUTICAL COMPOSITIONS AND METHODS FOR DELIVERING SUCH COMPOSITIONS | NEKTAR THERAPEUTICS (US) | 2012-10-11 | — | — | US | disclosed |
| US-8252275-B2 | Conjugates having a degradable linkage and polymeric reagents useful in preparing such conjugates | NEKTAR THERAPEUTICS (US) | 2012-08-28 | — | — | US | disclosed |
| EP-2279758-A2 | Conjugates having a degradable linkage and polymeric reagents useful in preparing such conjugates | Nektar Therapeutics (US) | 2011-02-02 | — | — | EP | disclosed |
| EP-1896082-A2 | CONJUGATES HAVING A DEGRADABLE LINKAGE AND POLYMERIC REAGENTS USEFUL IN PREPARING SUCH CONJUGATES | Nektar Therapeutics AL, Corporation (US) | 2008-03-12 | — | — | EP | disclosed |
| US-20060293499-A1 | Conjugates having a degradable linkage and polymeric reagents useful in preparing such conjugates | NEKTAR THERAPEUTICS | 2006-12-28 | — | — | US | disclosed |
| WO-2006138572-A2 | CONJUGATES HAVING A DEGRADABLE LINKAGE AND POLYMERIC REAGENTS USEFUL IN PREPARING SUCH CONJUGATES | NEKTAR THERAPEUTICS AL, CORPORATION (US) | 2006-12-28 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (9 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120258912-A1 | PHARMACEUTICAL COMPOSITIONS AND METHODS FOR DELIVERING SUCH COMPOSITIONS | ABCG2, SI, H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16 | MAPT 339/4885RAB9A 2000/4885ALDH1A1 1715/4885 |
| US-20220143201-A1 | COMPOSITION COMPRISING A POLYMERIC REAGENT | CD44, FCGRT, C9 | MAPT 1479/4885RAB9A 3754/4885ALDH1A1 898/4885 |
| US-20200276320-A1 | COMPOSITION COMPRISING A POLYMERIC REAGENT | CD44, FCGRT, C9 | MAPT 1479/4885RAB9A 3754/4885ALDH1A1 898/4885 |
| US-11266742-B2 | Conjugates having a degradable linkage and polymeric reagents useful in preparing such conjugates | CD44, DNPEP, SI | MAPT 1899/4885RAB9A 3259/4885ALDH1A1 492/4885 |
| US-11932726-B2 | Method of making releasable polymeric reagents | FGB, PCBP1, PFAS | MAPT 2710/4885RAB9A 683/4885ALDH1A1 1340/4885 |
| US-20130184443-A1 | Methods for Preparing Conjugates | SI, CD44, ABCG2 | MAPT 731/4885RAB9A 1640/4885ALDH1A1 979/4885 |
| US-20190046651-A1 | COMPOSITION COMPRISING A POLYMERIC REAGENT | CD44, FCGRT, C9 | MAPT 1479/4885RAB9A 3754/4885ALDH1A1 898/4885 |
| US-20210388161-A1 | METHOD OF MAKING RELEASABLE POLYMERIC REAGENTS | FGB, PCBP1, PFAS | MAPT 2710/4885RAB9A 683/4885ALDH1A1 1340/4885 |
| US-10695435-B2 | Composition comprising a polymeric reagent | CD44, FCGRT, C9 | MAPT 1479/4885RAB9A 3754/4885ALDH1A1 898/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.